Novel Intravenous Nanoemulsions Based on Cannabidiol-Enriche — 2025 Review/Other

Positive

Caffeine, nicotine, cannabis, and psilocybin: Pharmacology, toxicology, and potential therapeutic uses of four naturally occurring psychoactive substances

2025·Laboratory Study -

Inconclusive

Limited 12-hour pharmacokinetic assessment of CBD and CBDA isolates compared to their full-spectrum extracts in healthy adult beagles

2025·Review/Other

N/A

The use of cannabidiol (CBD) to improve sleep: a systematic review

2025·Meta-analysis -

Inconclusive

Recreational drugs repurposed for medicinal use—cannabis

2025·Review/Other

Inconclusive

Specific features of cannabidiol metabolism and excretion during long-term consumption of cannabis

2025·Review/Other

Inconclusive

Role of Lupinus Arboreus Extract in Cannabis-Induced Psychotic Behaviors in Wistar Rats

2025·Animal Study -

Novel Intravenous Nanoemulsions Based on Cannabidiol-Enriched Hemp Oil—Development and Validation of an HPLC-DAD Method for Cannabidiol Determination

Classification Results

Conditions Studied

Related Studies

Command Palette

Novel Intravenous Nanoemulsions Based on Cannabidiol-Enriched Hemp Oil—Development and Validation of an HPLC-DAD Method for Cannabidiol Determination

Classification Results

Conditions Studied

Related Studies